Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates
GLP-1s, a class of drugs used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have exploded in popularity in recent years due to their demonstrated effectiveness, but are often not covered by insurance, particularly for the treatment of obesity
He K, et al
3.1.3.1 Cardiac function and cardiac nerve damage LPS, a key component of Gram-negative bacterial cell walls, induces cardiac dysfunction by disrupting myocardial electrical activity and neural regulation, with the magnitude of its effects modulated by baseline disease status, sex differences, and individual adaptive responses
How it works: Directly stimulates muscle cell growth and proliferation
When IGF-1 is unchanged, the documented troubleshooting steps are to reassess dose timing (fasted state), injection technique, and peptide quality
US$ 25.90
US$ 23.10
